David Rizzieri Selected Research

Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)

1/2023	The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
5/2017	Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Rizzieri Research Topics

Disease

20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2007
19	Neoplasms (Cancer) 02/2024 - 01/2002
15	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022 - 06/2006
7	Leukemia 01/2021 - 02/2008
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 12/2013
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2020
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 12/2003
6	Lymphoma (Lymphomas) 11/2021 - 09/2004
6	Multiple Myeloma 12/2017 - 02/2008
5	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 06/2010
3	Pathologic Complete Response 01/2020 - 02/2006
3	Neutropenia 01/2020 - 07/2012
3	Thrombocytopenia (Thrombopenia) 01/2020 - 07/2012
3	Breast Neoplasms (Breast Cancer) 02/2006 - 01/2002
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 05/2017
2	Frailty 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 12/2021 - 08/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2020
2	Anemia 01/2021 - 07/2012
2	Fatigue 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2020 - 07/2012
2	Febrile Neutropenia 01/2020 - 07/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2019 - 11/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 02/2008
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2018 - 07/2012
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2013 - 02/2012
1	Primary Myelofibrosis (Myelosclerosis) 01/2023
1	Invasive Fungal Infections 11/2022
1	Cognitive Dysfunction 01/2022
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Epstein-Barr Virus Infections 12/2021
1	Inflammation (Inflammations) 01/2021
1	Blast Crisis (Blast Phase) 10/2020
1	monosomy Chromosome 7 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Hypophosphatemia 01/2020

Drug/Important Bio-Agent (IBA)

7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 01/2002
5	fludarabineIBA 11/2021 - 12/2007
4	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2015 - 04/2012
3	Busulfan (Busulfex)FDA Link 11/2021 - 05/2008
3	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 01/2010
3	Rituximab (Mabthera)FDA Link 10/2018 - 09/2004
3	guadecitabineIBA 01/2018 - 09/2015
3	Alkylating AgentsIBA 06/2010 - 02/2006
3	Cisplatin (Platino)FDA LinkGeneric 02/2006 - 01/2002
3	Carmustine (FIVB)FDA Link 02/2006 - 01/2002
2	Gemcitabine FDA Link 01/2023 - 07/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 07/2012
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2021 - 01/2020
2	Histone Deacetylase InhibitorsIBA 11/2021 - 01/2017
2	AntigensIBA 01/2020 - 08/2002
2	pixantrone (BBR 2778)IBA 10/2018 - 07/2012
2	5'-oleoyl cytarabineIBA 09/2014 - 04/2012
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2014 - 04/2012
2	Bortezomib (Velcade)FDA Link 03/2013 - 01/2010
2	Arsenic Trioxide (Trisenox)FDA Link 03/2013 - 06/2006
2	laromustine (VNP40101M)IBA 06/2010 - 01/2007
2	Diphtheria ToxinIBA 03/2008 - 12/2005
1	tagraxofuspIBA 02/2024
1	posaconazole FDA Link 11/2022
1	thymoglobulin FDA Link 12/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021
1	PanobinostatIBA 11/2021
1	Everolimus FDA Link 11/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	tremelimumabIBA 01/2021
1	pasireotideIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	danvatirsenIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	durvalumabIBA 01/2021
1	beta-DefensinsIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	nilotinib FDA Link 10/2019
1	Calcineurin InhibitorsIBA 01/2019
1	Bendamustine Hydrochloride FDA Link 10/2018
1	IpilimumabIBA 01/2018
1	Decitabine FDA Link 10/2017
1	Azacitidine (5 Azacytidine)FDA Link 10/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Histones (Histone)IBA 01/2017

Therapy/Procedure

17	Cell Transplantation 01/2023 - 01/2007
17	Therapeutics 11/2021 - 02/2006
12	Drug Therapy (Chemotherapy) 11/2022 - 01/2002
10	Transplantation 01/2023 - 05/2008
6	Stem Cell Transplantation 01/2023 - 08/2002
6	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2020
2	Induction Chemotherapy 11/2022 - 02/2006
2	Homologous Transplantation 11/2021 - 01/2021
2	Salvage Therapy 10/2018 - 07/2012
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2013 - 02/2006
1	Donor Selection 03/2022
1	Length of Stay 01/2022
1	MDC protocol 01/2022
1	Radioimmunotherapy 01/2019
1	Secondary Prevention 01/2018
1	Autologous Transplantation 01/2018